Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OPRD1 | P41143 | 13/20 | 0.54 |
| ▸ | OPRM1 | P35372 | 8/20 | 0.54 |
| ▸ | OPRK1 | P41145 | 2/20 | 0.52 |
| ▸ | NTSR2 | O95665 | 1/20 | 0.51 |
| ▸ | NTSR1 | P30989 | 1/20 | 0.51 |
| ▸ | ERAP2 | Q6P179 | 1/20 | 0.49 |
| ▸ | LNPEP | Q9UIQ6 | 1/20 | 0.49 |
| ▸ | F2 | P00734 | 1/20 | 0.48 |
| ▸ | KISS1R | Q969F8 | 2/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29472195 | 0.92 | F2 (0.52) | OPRD1OPRM1OPRK1NTSR2NTSR1 | |
| SCHEMBL9294767 | 0.91 | NTSR2 (0.59) | OPRD1OPRM1NTSR2NTSR1ERAP2 | |
| SCHEMBL9294748 | 0.91 | NTSR2 (0.59) | OPRD1OPRM1NTSR2NTSR1ERAP2 | |
| Laminin SCHEMBL2182800 | 0.89 | OPRD1 (0.55) | OPRD1OPRM1OPRK1KISS1R | |
| Laminin SCHEMBL29359946 | 0.89 | NTSR1 (0.56) | OPRD1OPRM1OPRK1NTSR2NTSR1 | |
| Laminin SCHEMBL29354054 | 0.89 | NTSR1 (0.56) | OPRD1OPRM1OPRK1NTSR2NTSR1 | |
| Laminin SCHEMBL2182807 | 0.89 | OPRD1 (0.55) | OPRD1OPRM1OPRK1KISS1R | |
| SCHEMBL29472198 | 0.89 | OPRD1 (0.58) | OPRD1OPRM1OPRK1 | |
| SCHEMBL30973964 | 0.88 | OPRD1 (0.54) | OPRD1OPRM1OPRK1ERAP2LNPEP | |
| SCHEMBL29780331 | 0.88 | NTSR1 (0.59) | NTSR2NTSR1ERAP2LNPEPF2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115353546-B | Preparation and application of oligopeptide modified bisindolylethyl-beta-carboline-3-carboxylic acid | 首都医科大学 | 2024-10-08 | — | — | CN | claimed |
| CN-115353546-A | Preparation and application of oligopeptide-modified bis-indolylethyl-beta-carboline-3-carboxylic acid | 首都医科大学 | 2022-11-18 | — | — | CN | claimed |
| CN-109134605-B | 1, 1-dihydroxymethyl-tetrahydro-beta-carboline-3-formyl-GYIGSK, and synthesis, activity and application thereof | 首都医科大学 | 2022-04-22 | — | — | CN | claimed |
| CN-115353546-B | Preparation and application of oligopeptide modified bisindolylethyl-beta-carboline-3-carboxylic acid | 首都医科大学 | 2024-10-08 | — | — | CN | disclosed |
| CN-115353546-B | Preparation and application of oligopeptide modified bisindolylethyl-beta-carboline-3-carboxylic acid | 首都医科大学 | 2024-10-08 | — | — | CN | disclosed |
| CN-115353546-A | Preparation and application of oligopeptide-modified bis-indolylethyl-beta-carboline-3-carboxylic acid | 首都医科大学 | 2022-11-18 | — | — | CN | disclosed |
| CN-115353546-A | Preparation and application of oligopeptide-modified bis-indolylethyl-beta-carboline-3-carboxylic acid | 首都医科大学 | 2022-11-18 | — | — | CN | disclosed |
| CN-109134605-B | 1, 1-dihydroxymethyl-tetrahydro-beta-carboline-3-formyl-GYIGSK, and synthesis, activity and application thereof | 首都医科大学 | 2022-04-22 | — | — | CN | disclosed |
| CN-109134603-B | 1, 1-dihydroxymethyl-tetrahydro-beta-carboline-3-formyl-GYIGSR, and synthesis, activity and application thereof | 首都医科大学 | 2022-04-22 | — | — | CN | disclosed |